Selection of carbapenemase KPC-14 in an Escherichia coli isolate
Genomic characterization of the in vivo selection of a KPC-14-producing Escherichia coli clinical isolate following cefiderocol treatment. The study aims to describe the emergence of ceftazidime/avibactam and cefiderocol resistance through mutations in the blaKPC-2 gene during antimicrobial therapy.